Generation of cytotoxic aptamers specifically targeting fibroblast-like synoviocytes by CSCT-SELEX for treatment of rheumatoid arthritis
Annals of the Rheumatic Diseases · 2025-05 · 84 (5) · 726-745
DOI: 10.1136/ard-2024-225565 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2025-05. Verfasst von Fang Qiu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China; Institute of Integrated Bioin…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Synoviocytes, Aptamers, Nucleotide, SELEX Aptamer Technique. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Hong Kong RGC Theme-based Research Scheme, Shanghai University of Traditional Chinese Medicine.
Abstract (Originalsprache)
OBJECTIVES: Rheumatoid arthritis (RA) is an autoimmune disease characterised by aggressive fibroblast-like synoviocytes (FLSs). Very few RA patients-derived FLSs (RA-FLSs)-specific surface signatures have been identified, and there is currently no approved targeted therapy for RA-FLSs. This study aimed to screen therapeutic aptamers with cell-targeting and cytotoxic properties against RA-FLSs and to uncover the molecular targets and mechanism of action of the screened aptamers. METHODS: We developed a cell-specific and cytotoxic systematic evolution of ligands by exponential enrichment (CSCT-SELEX) method to screen the therapeutic aptamers without prior knowledge of the surface signatures of RA-FLSs. The molecular targets and mechanisms of action of the screened aptamers were determined by pull-down assays and RNA sequencing. The therapeutic efficacy of the screened aptamers was examined in arthritic mouse models. RESULTS: We obtained an aptamer SAPT8 that selectively recognised and killed RA-FLSs. The molecular target of SAPT8 was nucleolin (NCL), a shuttling protein overexpressed on the surface and involved in the tumor-like transformation of RA-FLSs. Mechanistically, SAPT8 interacted with the surface NCL and was internalised to achieve lysosomal degradation of NCL, leading to the upregulation of proapoptotic p53 and downregulation of antiapoptotic B-cell lymphoma 2 (Bcl-2) in RA-FLSs. When administrated systemically to arthritic mice, SAPT8 accumulated in the inflamed FLSs of joints. SAPT8 monotherapy or its combination with tumour necrosis factor (TNF)-targeted biologics was shown to relieve arthritis in mouse models. CONCLUSIONS: CSCT-SELEX could be a promising strategy for developing cell-targeting and cytotoxic aptamers. SAPT8 aptamer selectively ablates RA-FLSs via modulating NCL-p53/Bcl-2 signalling, representing a potential alternative or complementary therapy for RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China; Institute of Integrated Bioinfomedicine and Translational Science (IBTS), School of Chinese Medicin…
- Department of Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
- LingGene Biotech Co., Ltd, Shenzhen, China.
- Department of Computational Biology, St Jude Children's Research Hospital, Memphis, TN, USA.
- Department of Rheumatology, Shanghai Guanghua Hospital of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China. Electronic address: fuxk@mail.sustech.edu.cn.
Förderung
- National Natural Science Foundation of China
- Hong Kong RGC Theme-based Research Scheme
- Shanghai University of Traditional Chinese Medicine
- 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund
- Southern University of Science and Technology
- Basic and Applied Basic Research Foundation of Guangdong Province
- Guangdong Basic and Applied Basic Research Foundation
- Shenzhen LingGene Biotech
Zitieren
APA
Qiu, F., Xie, D., Chen, H., Wang, Z., Huang, J., Cao, C., Liang, Y., Yang, X., He, D. Y., Fu, X., Lu, A., & Liang, C. (2025). Generation of cytotoxic aptamers specifically targeting fibroblast-like synoviocytes by CSCT-SELEX for treatment of rheumatoid arthritis. Annals of the Rheumatic Diseases, 84(5), 726-745. https://doi.org/10.1136/ard-2024-225565
Vancouver
Qiu F, Xie D, Chen H, Wang Z, Huang J, Cao C, et al. Generation of cytotoxic aptamers specifically targeting fibroblast-like synoviocytes by CSCT-SELEX for treatment of rheumatoid arthritis. Annals of the Rheumatic Diseases. 2025;84(5):726-745. doi:10.1136/ard-2024-225565
BibTeX
@article{Qiu2025,
author = {Qiu, Fang and Xie, Duoli and Chen, Hongzhen and Wang, Zhuqian and Huang, Jie and Cao, Chunhao and Liang, Yiying and Yang, Xu and He, Dong-Yi and Fu, Xuekun and Lu, Aiping and Liang, Chao},
title = {Generation of cytotoxic aptamers specifically targeting fibroblast-like synoviocytes by CSCT-SELEX for treatment of rheumatoid arthritis},
journal = {Annals of the Rheumatic Diseases},
year = {2025},
volume = {84},
number = {5},
pages = {726--745},
doi = {10.1136/ard-2024-225565}
}
EUVIMED